All patient queries receive a response, explaining that they need to discuss the issue with their doctor and offering the possibility for their oncologist to contact oncologists and researchers at hospitals where PharmaMar compounds are undergoing clinical trials with a view to possible participation in a clinical trial if the patient's specific case is appropriate and complies with the protocols.